Itamar Medical Ltd. announced the launch of SleePath, the first integrated e-health sleep apnea care pathway monitoring system to monitor atrial fibrillation (AF) patients’ sleep apnea management status and compliance with continuous positive airway pressure (CPAP) devices on demand.

“Disruptive innovation” is all the buzz. Repealing the Affordable Care Act (ACA) is so last year. Well, disrupt this: Repeal Medicare and Medicaid and get the government out of the medical care business.

Marilyn M. Singleton, M.D., JD, is a board-certified anesthesiologist and Board of Directors member and president-elect of Association of American Physicians and Surgeons

How coronary artery plaque forms and becomes a vulnerable plaque leading to a heart attack.

As a cardiologist practicing at the Orange County Heart Institute and St. Joseph Hospital in Orange, my mission is to positively impact heart health and quality of life for people, not only in my community, but around the globe. Nothing is more satisfying than helping a patient with education, prevention and treatment of complex heart problems. When patients learn about the intricacies of the heart, it helps them better understand how they can prevent heart attack, stroke and peripheral vascular disease, high cholesterol, high blood pressure, diabetes and blood clots.

Society of Vascular Medicine (SVM)

Israel-based V-Wave Ltd. recently closed a $70 million Series C financing for its proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF). The financing round was led by Deerfield Management, along with participation from new investors – healthcare funds Endeavour Vision, Quark Venture and Aperture Venture Partners. All of V-Wave's existing major investors are also participating in this round, including strategic investors Johnson & Johnson Innovation (JJDC Inc.) and Edwards Lifesciences, along with BRM Group, Pontifax, Pura Vida Investments, TriVentures, BioStar Ventures and Israel Secondary Fund.

Boston Scientific announced results from an analysis of the LATITUDE database evaluating the successful reduction of inappropriate shocks using the Smart Pass sensing filter with the Emblem Subcutaneous Implantable Defibrillator (S-ICD) System. The real-world data were presented during a late-breaking clinical trial at Heart Rhythm 2018, the Heart Rhythm Society's 39th Annual Scientific Sessions, May 9-12 in Boston. The results demonstrated that when the sensing filter was in use, the rate of inappropriate shocks was reduced to 4.3 percent at one year.

May 15, 2018 — A new study is the first to report a relationship between post-traumatic stress disorder (PTSD) and new cases of atrial fibrillation (AF), the most common heart arrhythmia. The large nationwide study included more than 1 million patients with no prior history of AF or atrial flutter. The study was at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions.  

May 15, 2018 — According to new research, smoking marijuana may not be associated with an increased risk of ventricular fibrillation (VF) and ventricular tachycardia (VT) following an acute myocardial infarction (AMI). The study also reported that marijuana users had a decreased risk of atrial fibrillation (AFib) and in-hospital mortality.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now